Successful treatment with infliximab and low-dose methotrexate in a Japanese patient with familial Mediterranean fever

Internal Medicine

Volumn 46, Issue 15, 2007, Pages 1247-1249

  Nakamura, Akinori ^a   Matsuda, Masayuki ^a   Tazawa, Ko Ichi ^a   Shimojima, Yasuhiro ^a   Ikeda, Shu Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Familial Mediterranean fever; Infliximab; Methotrexate; Tumor necrosis factor

Indexed keywords

ALPHA INTERFERON; ANTIINFLAMMATORY AGENT; AZELASTINE; C REACTIVE PROTEIN; CHROMOSOME PROTEIN; COLCHICINE; DICLOFENAC; INFLIXIMAB; INTERLEUKIN 1BETA; MARENOSTRIN; MEDITERRANEAN FEVER PROTEIN; METHOTREXATE; MONOCLONAL ANTIBODY; NUCLEAR FACTOR; PRAZOSIN; RESERPINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; ANTIRHEUMATIC AGENT;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ADULT; ARTHRALGIA; ARTICLE; BONE MARROW SUPPRESSION; CASE REPORT; COMBINATION CHEMOTHERAPY; DAILY LIFE ACTIVITY; DIARRHEA; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FAMILIAL MEDITERRANEAN FEVER; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GENE MUTATION; GENERAL CONDITION IMPROVEMENT; HETEROZYGOSITY; HUMAN; JAPANESE; LOW DRUG DOSE; MALAISE; MENSTRUATION; MONOTHERAPY; RECURRENT FEVER; STRESS; TREATMENT REFUSAL; DOSE RESPONSE; DRUG COMBINATION; IMMUNOLOGY;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; METHOTREXATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548075550     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.0064     Document Type: Article

References (18)

1. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 43: 227-253, 1967.
2. Ben-Chetrir E, Levy M. Familial Mediterranean fever. Lancet 351: 659-664, 1998.
3. Hayashi A, Suzuki T, Shimazu A, Yamamura Y. Periodic fever suppressed by reserpine. Lancet 1: 592, 1976.
4. Kataoka H, Kumagai H, Hanai Y. Treating familial Mediterranean fever with prazosin hydrochloride. Ann Intern Med 129: 424-425, 1998.
5. Tunca M, Tankurt E, Akbaylar Akpinar H, Akar S, Hizli N, Gonen O. The efficacy of interferon alpha on colchicines resistant familial Mediterranean fever attacks: a pilot study. Br J Rheumatol 36: 1005-1008, 1997.
6. Seyahi E, Ozdogan H, Masatlioglu S, Yazici H. Successful treatment of familial Mediterranean fever attacks with thalidomide in a colchicines resistant patient. Clin Exp Rheumatol 20: S43-S44, 2002.
7. Komatsu M, Takahashi T, Uemura N, Takada G. Familial Mediterranean fever medicated with an herbal medicine in Japan. Pediatr Int 46: 81-84, 2004.
8. Nakamura A, Yazaki M, Tokuda T, Hattori T, Ikeda S. A Japanese patient with familial Mediterranean fever associated with compound heterozygosity for pyrin variant E148Q/M694I. Intern Med 44: 261-265, 2005.
9. Milledge J, Shaw PJ, Mansour A, et al. Allogeneic bone marrow transplantation: cure for familial Mediterranean fever. Blood 100: 774-777, 2002.
10. Aldea A, Campistol J, Arostegui JI, et al. A severe autosomal-dominant periodic inflammatory disorder with renal AA amyloidosis and colchicine resistance associated to the MEFV H478Y variant in a Spanish kindred: an unusual familial Mediterranean fever phenotype or another MEFV-associated periodic inflammatory disorder? Am J Med Genet 124: 67-73, 2004.
11. Ozgocmen S, Özçkar L, Ardicoglu O, Kocakoc E, Kaya A, Kiris A (2005) Familial Mediterranean fever responds well to infliximab: single case experience. Clin Rheumatol 25: 83-87.
12. Shinozaki K, Agematsu K, Yasui K, et al. Familial Mediterranean fever in 2 Japanese families. J Rheumatol 29: 1324-1325, 2002.
13. Drenth JP, van der Meer JW. Hereditary periodic fever. N Engl J Med 345: 1748-1757, 2001.
14. Takeuchi T. Anti-TNF biological agents in rheumatoid arthritis and other inflammatory diseases. Allergol Int 54: 191-202, 2005.
15. Seyahi E, Ozdogan H, Celik S, Ugurlu S, Yazici H. Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents. Clin Exp Rheumatol 24 (Suppl 42): S99-S103.
16. Mor A, Pillinger MH, Kishimoto M, Abeles AM, Livneh A. Familial Mediterranean fever successfully treated with etanercept. J Clin Rheumatol 13: 38-40, 2007.
17. Baykal Y, Saglam K, Yimaz I, Taslipinar A, Akinci SB, Inal A. Serum sIL-2r, IL-6, IL-10 and TNF-α level in familial Mediterranean fever patients. Clin Rheumatol 22: 99-101, 2003.
18. Chae JJ, Komarow HD, Cheng J, et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 11: 591-604, 2003.